468075-00-5

Basic information

• Product Name: 2-BROMO-1-CHLORO-4-(TRIFLUOROMETHOXY)BENZENE
• Synonyms: 2-Bromo-1-chloro-4-(trifluoromethoxy)benzen;3-BroMo-4-chloro-1-(trifluoroMethoxy)benzene
• CAS NO: 468075-00-5
• Molecular Formula: C₇H₃BrClF₃O
• Molecular Weight: 275.45
• Product Categories: Fluorine series
• Mol File: 468075-00-5.mol

Chemical Properties

• Boiling Point: 205℃
• Flash Point: 78℃
• Appearance: /
• Density: 1.743
• Vapor Pressure: 0.366mmHg at 25°C
• Refractive Index: 1.493
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: 2-BROMO-1-CHLORO-4-(TRIFLUOROMETHOXY)BENZENE(CAS DataBase Reference)
• NIST Chemistry Reference: 2-BROMO-1-CHLORO-4-(TRIFLUOROMETHOXY)BENZENE(468075-00-5)
• EPA Substance Registry System: 2-BROMO-1-CHLORO-4-(TRIFLUOROMETHOXY)BENZENE(468075-00-5)

Safety Data

• HazardClass: IRRITANT
• Hazardous Substances Data: 468075-00-5(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
2-Bromo-1-chloro-4-(trifluoromethoxy)benzene is used as a key intermediate in the synthesis of various pharmaceuticals. Its unique structure allows for the development of new drugs with specific therapeutic properties, contributing to the advancement of medicinal chemistry.
Used in Agrochemical Industry:
In the agrochemical sector, 2-Bromo-1-chloro-4-(trifluoromethoxy)benzene serves as an essential building block for the creation of novel agrochemicals. Its incorporation into these compounds can enhance their effectiveness in pest control and crop protection, thereby supporting agricultural productivity.
Used in Fine Chemicals Industry:
2-Bromo-1-chloro-4-(trifluoromethoxy)benzene is utilized as a versatile intermediate in the synthesis of fine chemicals. Its presence in these compounds can impart specific functional groups and properties, making it valuable for applications in various chemical processes and products.
Used in Environmental Research:
Although identified as a potential environmental contaminant, 2-Bromo-1-chloro-4-(trifluoromethoxy)benzene also plays a role in environmental research. Its study helps in understanding the behavior of similar compounds in the environment, their potential impact on human health, and the development of strategies for their safe handling and disposal.

InChI:InChI=1/C7H3BrClF3O/c8-5-3-4(1-2-6(5)9)13-7(10,11)12/h1-3H

Upstream product

• 175278-17-8 2-bromo-4-trifluoromethoxyaniline 
• 544-16-1 n-Butyl nitrite 

Downstream Products

• 1331753-36-6 11-phenyl-7-(trifluoromethoxy)dibenzo[b,f][1,4]oxazepine 
• 1331753-49-1 1-(2-((2-chloro-5-(trifluoromethoxy)phenyl)amino)phenyl)-2,2-dimethylpropanone 
• 1331753-45-7 (2-((2-chloro-5-(trifluoromethoxy)phenyl)amino)phenyl)(phenyl)methanone 
• 1331753-28-6 11-phenyl-7-(trifluoromethoxy)-5H-dibenzo[b,e][1,4]diazepine 
• 1599479-25-0 2-(9-(2-chloro-5-(trifluoromethoxy)phenyl)-1-oxa-9-azaspiro [5.5]undecan-3-yl)acetonitrile 
• 1599478-97-3 methyl 2-(3-(2-chloro-5-(trifluoromethoxy)phenyl)-3-azaspiro[5.5]undecan-9-yl)acetate 
• 1599477-76-5 2-(3-(2-chloro-5-(trifluoromethyl)phenyl)-3-azaspiro[5.5]undecan-9-yl)acetic acid 
• 1599477-77-6 (rac) 2-(3-(2-chloro-5-(trifluoromethoxy)phenyl)-3-azaspiro[5.5]undecan-9-yl)propanoic acid 
• 1599477-78-7 rac-2-(3-(2-chloro-5-(trifluoromethoxy)phenyl)-3-azaspiro[5.5]undec-8-en-9-yl)propanoic acid 
• 1599479-01-2 rac-ethyl 2-(3-(2-chloro-5-(trifluoromethoxy)phenyl)-3-azaspiro[5.5 ]undec-9-yl)propanoate 
• 1599479-02-3 rac-ethyl 2-(3-(2-chloro-5-(trifluoromethoxy)phenyl)-3-azaspiro[5.5]undec-8-en-9-yl)propanoate 
• 1599479-13-6 ethyl 2-(3-(2-chloro-5-(trifluoromethoxy)phenyl)-8-methyl-3-azaspiro[5.5]undecan-9-yl)acetate 
• 1261649-12-0 2-chloro-5-trifluoromethoxy-benzoic acid methyl ester 
• 1419075-84-5 4-bromo-2-chloro-5-trifluoromethoxy-benzoic acid 

Relevant articles and documents

GLYCOLATE OXIDASE INHIBITORS FOR THE TREATMENT OF DISEASE

Described herein are compounds, methods of making such compounds, pharmaceutical compositions and medicaments containing such compounds, and methods of using such compounds to treat or prevent diseases or disorders associated with a defect in glyoxylate metabolism, for example a disease or disorder associated with the enzyme glycolate oxidase (GO) or alterations in oxalate metabolism. Such diseases or disorders include, for example, disorders of glyoxylate metabolism, including primary hyperoxaluria, that are associated with production of excessive amounts of oxalate.

GLYCOLATE OXIDASE INHIBITORS FOR THE TREATMENT OF DISEASE

Described herein are compounds, methods of making such compounds, pharmaceutical compositions and medicaments containing such compounds, and methods of using such compounds to treat or prevent diseases or disorders associated with the enzyme glycolate oxidase (GO). Such diseases or disorders include, for example, disorders of glyoxylate metabolism, including primary hyperoxaluria, that are associated with production of excessive amounts of oxalate.

Pyrido[4,3- e ][1,2,4]triazolo[4,3- a ]pyrazines as selective, brain penetrant phosphodiesterase 2 (PDE2) inhibitors

A novel series of pyrido[4,3-e][1,2,4]triazolo[4,3-a]pyrazines is reported as potent PDE2/PDE10 inhibitors with drug-like properties. Selectivity for PDE2 was obtained by introducing a linear, lipophilic moiety on the meta-position of the phenyl ring pending from the triazole. The SAR and protein flexibility were explored with free energy perturbation calculations. Rat pharmacokinetic data and in vivo receptor occupancy data are given for two representative compounds 6 and 12.

AZABICYCLIC AMINE DERIVATIVES AS NK-1 RECEPTOR ANTAGONISTS

The present invention relates compounds of the formula (I), wherein X represents hydrogen or a C1-4alkyl group optionally substituted by a hydroxy group; Y represents hydrogen, C1-6alkyl or C3-7cycloalkyl; Z is -CR9/